Atlas Trials

Distal Myopathy, Nonaka Type

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Distal Myopathy, Nonaka Type

RecordFirmDate
Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) (NCT02736188)Ultragenyx Pharmaceutical Inc2016-05-02
A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment (NCT02731690)Ultragenyx Pharmaceutical Inc2016-04-29
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) (NCT02377921)Ultragenyx Pharmaceutical Inc2015-05-20

Track Distal Myopathy, Nonaka Type automatically

Every clearance here is in the API, with alerts when new ones post.